Visceral Adiposity Index
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To individuate a novel sex-specific index, based on waist circumference, BMI, triglycerides, and HDL cholesterol, indirectly expressing visceral fat function. RESEARCH DESIGN AND METHODS: Visceral adiposity index (VAI) was first modeled on 315 nonobese healthy subjects. Using two multiple logistic regression models, VAI was retrospectively validated in 1,498 primary care patients in comparison to classical cardio- and cerebrovascular risk factors. RESULTS: All components of metabolic syndrome increased significantly across VAI quintiles. VAI was independently associated with both cardiovascular (odd ratio [OR] 2.45; 95% CI 1.52–3.95; P < 0.001) and cerebrovascular (1.63; 1.06–2.50; P = 0.025) events. VAI also showed significant inverse correlation with insulin sensitivity during euglycemic-hyperinsulinemic clamp in a subgroup of patients (Rs = −0.721; P < 0.001). By contrast, no correlations were found for waist circumference and BMI. CONCLUSIONS: Our study suggests VAI is a valuable indicator of “visceral adipose function” and insulin sensitivity, and its increase is strongly associated with cardiometabolic risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“increased fat mass is associated with elevated adipocytokine and proinflammatory cytokines, insulin resistance, increased risk of developing adverse outcomes of diabetes, hypertriglyceridemia, hypercholesterolemia, hypertension, atherosclerosis, and a higher mortality rate [10].”
From Trend of various adiposity indices in women with and without history of gestational diabetes: a population-based cohort study (2019) · cites this paper as [10]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pouliot, M.-C., Després, J.-P., Lemieux, S., Moorjani, S., Bouchard, C., Tremblay, A., Nadeau, A., & Lupien, P. J. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90676-9 · Cited by 2,085
Ohlson, L. O., Larsson, B., Svärdsudd, K., Welin, L., Eriksson, H., Wilhelmsen, L., Björntorp, P., & Tibblin, G. (1985) · Diabetes · doi:10.2337/diab.34.10.1055 · Cited by 1,020
Unger, R. H. (2003) · Endocrinology · doi:10.1210/en.2003-0870 · Cited by 677 · cited 1×
“Indeed, this condition characterized by visceral obesity and “high-triglyceride/low–HDL cholesterol dyslipidemia” has been associated with physiological age-linked leptin resistance, muscle, and liver insulin resistance, lipotoxic cardiomyopathy, and generalized endothelial dysfunction (15).”
BackgroundIs visceral obesity the cause of the metabolic syndrome?
Després, J. (2006) · Annals of Medicine · doi:10.1080/07853890500383895 · Cited by 651
Age-related inflammatory cytokines and disease
Brüünsgaard, H., & Pedersen, B. K. (2003) · Immunology and Allergy Clinics of North America · doi:10.1016/s0889-8561(02)00056-5 · Cited by 608 · cited 1×
“V isceral obesity (1) is associated with increased adipocytokine production, proinflammatory activity (2), deterioration of insulin sensitivity (3), increased risk of developing diabetes, “high-triglyceride/low–HDL cholesterol dyslipidemia,” hypertension, atherosclerosis, and higher mortality rate (4–7).”
BackgroundSubdivisions of subcutaneous abdominal adipose tissue and insulin resistance
Kelley, D. E., Thaete, F. L., Troost, F., Huwe, T., & Goodpaster, B. H. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.278.5.e941 · Cited by 538
Body fat distribution, insulin resistance, and metabolic diseases
Björntorp, P. (1997) · Nutrition · doi:10.1016/s0899-9007(97)00191-3 · Cited by 470
High Visceral and Low Abdominal Subcutaneous Fat Stores in the Obese Adolescent
Taksali, S. E., Caprio, S., Dziura, J., Dufour, S., Calí, A. M. G., Goodman, T. R., Papademetris, X., Burgert, T. S., Pierpont, B. M., Savoye, M., et al. (2008) · Diabetes · doi:10.2337/db07-0932 · Cited by 353
Rader, D. J. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.01.003 · Cited by 346
Visceral Fat in Hypertension: Influence on Insulin Resistance and β-Cell Function
Sironi, A. M., Gastaldelli, A., Mari, A., Ciociaro, D., Postano, V., Buzzigoli, E., Ghione, S., Turchi, S., Lombardi, M., & Ferrannini, E. (2004) · Hypertension · doi:10.1161/01.hyp.0000137982.10191.0a · Cited by 268
Research works printed but not linked: 1
- De Fronzo, 1979, The glucose clamp technique: a method for the quantification of beta cell sensitivity to glucose and of tissue sensitivity to insulin, Am J Physiol, 237, 214
Cited by
Items 601–700 of 1,005
Julián, M. T., Arteaga, Í., Torán‐Monserrat, P., Pera, G., de, A. P.-M., Ruiz-Rojano, I., Casademunt-Gras, E., Chacón, C., & Alonso, N. (2024) · Nutrients · doi:10.3390/nu16111586 · Cited by 19
Liu, Y. F., Wang, Y., Xing, Y., Wolters, M., Shi, D., Zhang, P., Dang, J., Chen, Z., Cai, S., Wang, Y., et al. (2024) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2024.101150 · Cited by 19
Long, J., Li, L., Wang, F., Yang, G., Cheng, W., Wei, J., Chen, M., & Liu, D. (2019) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2019.0019 · Cited by 19
Visceral adiposity index is associated with silent brain infarct in a healthy population
Nam, K., Kwon, H., Jeong, H., Park, J., Kwon, H., Jeong, S., & Kim, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-74454-6 · Cited by 19
Association of adiposity indicators with hypertension among Chinese adults
Wang, C., Fu, W., Cao, S., Xu, H., Tian, Q., Gan, Y., Guo, Y., Yan, S., Yan, F., Yue, W., et al. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.01.001 · Cited by 19
Ferreira, F. G., Reitz, L. K., Valmorbida, A., Gabiatti, M. P., Hansen, F., Pietro, P. F. D., de Oliveira, L. L., Trindade, E. B. S. D. M., & Longo, G. Z. (2022) · Nutrition · doi:10.1016/j.nut.2022.111590 · Cited by 19
Shi, W., Chen, J., He, Y., Su, P., Wang, M., Li, X., & Tang, D. (2022) · Journal of Exercise Science & Fitness · doi:10.1016/j.jesf.2022.09.001 · Cited by 19
Diagnostic value of visceral adiposity index in chronic kidney disease: a meta-analysis
Fang, T., Zhang, Q., Wang, Y., & Zha, H. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02048-5 · Cited by 19
Huang, L., Liu, H., Li, L., Wang, S., & Sun, G. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1283545 · Cited by 19
“While WC exhibits better sensitivity to obesity, particularly abdominal obesity (15), its use as a solitary measure remains inadequate for distinguishing between subcutaneous and visceral fat deposits (27, 28).”
BackgroundSerum visfatin levels in acromegaly: Correlation with disease activity and metabolic alterations
Ciresi, A., Amato, M. C., Pizzolanti, G., & Giordano, C. S. D. S. (2015) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2015.07.002 · Cited by 19
Self-citationDu, T., Yuan, G., Zhou, X., & Sun, X. (2016) · Annals of Medicine · doi:10.3109/07853890.2015.1127406 · Cited by 19
Ün, B., Dolapçıoğlu, K., Okyay, A. G., Şahin, H. N., & Beyazıt, A. (2016) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.06.022 · Cited by 19
Qing, L., Wei, R., Chan, L., Zheng, X., & Xin, X.-J. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0621-2 · Cited by 19
“Recently, the AlkaMeSy Study Group introduced a index, named visceral adiposity index (VAI), which comprises simple anthropometric parameters including body mass index (BMI), waist circumference (WC) and metabolic parameters [triglycerides (TG) and high-density lipoprotein cholesterol (HDL-C)], which was used as a mar…”
BackgroundMethodInfluentialBeşiroğlu, H., Özbek, E., Dursun, M., & Ötünçtemur, A. (2017) · The Aging Male · doi:10.1080/13685538.2017.1365833 · Cited by 19
Mazidi, M., Gao, H.-K., & Kengne, A. P. (2018) · Medicine · doi:10.1097/md.0000000000010322 · Cited by 19
Rivera‐Paredez, B., Hidalgo‐Bravo, A., León‐Reyes, G., León-Maldonado, L. S., Aquino‐Gálvez, A., Castillejos-López, M. D. J., Denova‐Gutiérrez, E., Flóres, Y. N., Salmerón, J., & Velázquez‐Cruz, R. (2021) · Nutrients · doi:10.3390/nu13103320 · Cited by 19
Visceral Adipose Tissue Phospholipid Signature of Insulin Sensitivity and Obesity
Palau‐Rodriguez, M., Marco‐Ramell, A., Casas‐Agustench, P., Tulipani, S., Miñarro, A., Sánchez‐Pla, Á., Murri, M., Tinahones, F. J., & Andrés‐Lacueva, C. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00918 · Cited by 18
Association of visceral adiposity index with sarcopenia based on NHANES data
Li, J., Lin, Y., Deng, H., Su, X., Feng, W., Shao, Q., & Zou, K. (2024) · Scientific Reports · doi:10.1038/s41598-024-72218-0 · Cited by 18
Zhou, J., Yu, W., Jiang, G., Li, H., Luo, J., Li, S., Xie, L., Bai, X., Xia, J., Mao, M., et al. (2025) · Obesity Facts · doi:10.1159/000545346 · Cited by 18
Cosenza, B. (2012) · Expert Systems with Applications · doi:10.1016/j.eswa.2012.02.198 · Cited by 18
Visceral Adiposity Index Levels in Patients with Hypothyroidism
Pekgör, S., Duran, C., Kutlu, R., Solak, İ., Pekgör, A., & Eryılmaz, M. A. (2018) · Journal of the National Medical Association · doi:10.1016/j.jnma.2018.03.009 · Cited by 18
HEART REMODELING IN OVERWEIGHT AND OBESITY WITH CARDIAC COMORBIDITIES
Логачева, И. В., Ryazanova, Т. A., Makarova, V. R., Avzalova, F. R., & Максимов, Н. И. (2017) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2017-4-40-46 · Cited by 18
Pediatric Visceral Adiposity Index Adaptation Correlates with Homa-Ir, Matsuda, and Transaminases
Hernández, M. I. A. E. E. S., Klünder‐Klünder, M., Garibay-Nieto, N., Alvarenga, J. C. L., Vilchis‐Gil, J., Huerta, S. F., Siccha, R. E., & Hernández-Ruiz, J. (2018) · Endocrine Practice · doi:10.4158/ep-2017-0086 · Cited by 18
Banitalebi, E., Ghahfarrokhi, M. M., Faramarzi, M., & Earnest, C. P. (2021) · The Journal of Sports Medicine and Physical Fitness · doi:10.23736/s0022-4707.20.11105-8 · Cited by 18
Wung, C.-H., Lee, M., Wu, P.-Y., Huang, J., & Chen, S. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11060533 · Cited by 18
Hudzik, B., Nowak, J., Szkodziński, J., & Zubelewicz‐Szkodzińska, B. (2021) · Nutrients · doi:10.3390/nu13072351 · Cited by 18
“Sex-specific formulae were used to calculate VAI [12].”
MethodTürkmen, K., Özer, H., & Kusztal, M. A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11051308 · Cited by 18
Banu, H., Morshed, M. S., Sultana, T., Shah, S., Afrine, S., & Hasanat, M. A. (2022) · Journal of Human Reproductive Sciences · doi:10.4103/jhrs.jhrs_114_21 · Cited by 18
Zhou, C., Zhang, Y., Yang, S., He, P., Wu, Q., Ye, Z., Liu, M., Zhang, Y., Li, R., Liu, C., et al. (2022) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3602 · Cited by 18
Nogueira, M. D. D. A., Braga, R. A. M., Μanios, Y., Androutsos, O., Molnár, D., Polito, A., Gómez‐Martínez, S., Béghin, L., Widhalm, K., Bueno, G., et al. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.01.015 · Cited by 18
Pan, W. D., Wang, M., Hu, Y., Lian, Z., Cheng, H., Qin, J., & Wan, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1221325 · Cited by 18
Motta, B. M., Grander, C., Gögele, M., Foco, L., Vuković, V., Melotti, R., Fuchsberger, C., Grandi, A. D., Cantaloni, C., Picard, A., et al. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-02130-z · Cited by 18
Okada, K., Nishigori, T., Obama, K., Tsunoda, S., Hida, K., Hisamori, S., & Sakai, Y. (2019) · Journal of Oncology · doi:10.1155/2019/8404383 · Cited by 18
“Excess visceral fat is known to be associated with metabolic syndrome and a risk of serious diseases, such as type 2 diabetes [23–26].”
Sanayei, M., Izadi, A., Hajizadeh‐Sharafabad, F., Amirsasan, R., Kaviani, M., & Barzegar, A. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00816-0 · Cited by 17
Giannouli, A., Efthymiou, V., Konidari, M., Mani, I., Aravantinos, L., Dourakis, S. P., Antoniou, A., Deligeoroglou, E., & Bacopoulou, F. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12020557 · Cited by 17
Seo, M.-W., & Kim, J. Y. (2023) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2023.02.001 · Cited by 17
Guo, Y., Hu, Y., Yang, J., Ma, R., Zhang, X., Guo, H., Wang, X., Li, Y., Peng, X., Zhang, S., et al. (2023) · European journal of medical research · doi:10.1186/s40001-023-01536-2 · Cited by 17
Xu, M., Zhou, H., Zhang, R., Pan, Y., & Liu, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1301284 · Cited by 17
“The determination of VAI necessitates the integration of body mass index (BMI), waist circumference (WC), triglyceride (TG), and high-density lipoprotein (HDL) cholesterol by means of a mathematical equation (11).”
BackgroundHe, Q., Wang, Y., Feng, Z., Chu, J., Li, T., Hu, W., Chen, X., Han, Q., Sun, N., Liu, S. J., et al. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.12.024 · Cited by 17
Citarrella, R., Chianetta, R., Amodeo, S., Mirarchi, L., Licata, A., Soresi, M., Veronese, N., Barbagallo, M., & Giannitrapani, L. (2024) · Nutrients · doi:10.3390/nu16020249 · Cited by 17
“Visceral adiposity index (VAI) was calculated using a combination of waist circumference, body mass index (BMI), triglycerides and high-density lipoproteins (LDL), using the equations proposed in [15].”
MethodChen, P., Lu, Y., Lu, S., Liang, F., & Chuang, H. (2024) · Journal of Epidemiology and Global Health · doi:10.1007/s44197-024-00275-9 · Cited by 17
Mohan, V., Manasa, V. S., Abirami, K., Unnikrishnan, R., Gayathri, R., Geetha, G., RamyaBai, M., Padmavathi, S., Rajalakshmi, M., Pradeepa, R., et al. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01622-6 · Cited by 17
Cavalcante, R. B. D. M., Leão, L. M. C. S. M., Tavares, A. B. W., Lopes, K. G., & Kraemer‐Aguiar, L. G. (2024) · Hormone and Metabolic Research · doi:10.1055/a-2386-9281 · Cited by 17
American Society for Metabolic and Bariatric Surgery review of the body mass index
Carter, J. T., Husain, F. A., Papasavas, P. K., Docimo, S., Albaugh, V. L., Aylward, L., Blalock, C. A., & Benson‐Davies, S. (2024) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2024.10.038 · Cited by 17
The Value of TyG‐Related Indices in Evaluating MASLD and Significant Liver Fibrosis in MASLD
Zou, H., Xie, J., Ma, X., & Xie, Y. (2025) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/cjgh/5871321 · Cited by 17
Cheng, N., Chen, Y., Jin, L., & Chen, L. (2025) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-025-03076-7 · Cited by 17
Zeng, Q., Dong, S.-Y., Wang, M.-L., Li, J., Ren, C., & Gao, C. (2016) · Preventive Medicine · doi:10.1016/j.ypmed.2016.08.001 · Cited by 17
“VAI was calculated by the published formula: (Amato et al., 2010) (waist circumference / (39.”
MethodInfluentialCiresi, A., Radellini, S., Guarnotta, V., & Giordano, C. S. D. S. (2016) · Endocrine · doi:10.1007/s12020-016-1076-5 · Cited by 17
Self-citationKe, Z., Li, F., Gao, Y., Tan, D., Sun, F., Zhou, X., Chen, J., Lin, X., Zhu, Z., & Tong, W. (2020) · Obesity Surgery · doi:10.1007/s11695-020-05034-w · Cited by 17
da Silva, B. R., Rufato, S., Mialich, M. S., Cruz, L. P., Gozzo, T. D. O., & Jordão, A. A. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.06.001 · Cited by 17
Martínez‐Sánchez, F. D., Vargas-Abonce, V. P., Rocha-Haro, A., Flores-Cárdenas, R., Fernández-Barrio, M., Guerrero-Castillo, A. P., Meza-Arana, C. E., Gulías-Herrero, A., & Gómez-Sámano, M. Á. (2021) · Diabetes Epidemiology and Management · doi:10.1016/j.deman.2021.100013 · Cited by 17
Karataş, S., & Beysel, S. (2021) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2021.0047 · Cited by 17
“6 The formula VAI includes three of the MetS criteria (TG, HDL-c, and WC).”
Jao, H.-F., Wung, C.-H., Yu, H.-C., Lee, M., Chen, P., Chen, S., & Chang, J. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.63180 · Cited by 17
Xue, S., Han, H., Rui, S., Yang, M., Huang, Y., Zhan, B., Geng, S., Liu, H., Chen, C., Yang, G., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6657658 · Cited by 17
Li, J., Zhu, J. Q., Tan, Z., Yu, Y., Luo, L., Zhou, W., Zhu, L., Wang, T., Cao, T., Liu, L., et al. (2021) · Nutrition & Metabolism · doi:10.1186/s12986-021-00617-5 · Cited by 17
Li, H., Wang, Q., Ke, J., Lin, W., Luo, Y., Yao, J., Zhang, W., Zhang, L. R., Duan, S., Dong, Z., et al. (2022) · Nutrients · doi:10.3390/nu14071334 · Cited by 17
GREM2 is associated with human central obesity and inhibits visceral preadipocyte browning
Liu, W., Li, D., Yang, M., Wang, L., Xu, Y., Chen, N., Zhang, Z., Shi, J., Li, W., Zhao, S., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103969 · Cited by 17
Pérez-Castro, E., Godínez-Jaimes, F., Vázquez‐Medina, M. U., Ocharan-Hernández, M. E., & Vargas‐De‐León, C. (2022) · Scientific Reports · doi:10.1038/s41598-022-10963-w · Cited by 17
Lin, M., Li, N., Heizhati, M., Gan, L., Zhu, Q., Yao, L., Li, M., & Yang, W. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.910329 · Cited by 17
Park, J. H., Lim, N.-K., & Park, H. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.930922 · Cited by 17
“(2010) developed the VAI, which is based on the waist circumference, BMI, TG, and HDL-C (Amato et al., 2010), that has been considered a surrogate marker of both fat distribution and VAD and has shown positive and significant associations with hypertension, cardiometabolic risk, diabetes mellitus, and FIGURE 3 |Odds r…”
BackgroundMethodInfluentialBusquets-Cortés, C., López, C., Paublini, H., Bote, S. A., López‐González, Á. A., & Ramírez‐Manent, J. I. (2022) · Journal of Nutrition and Metabolism · doi:10.1155/2022/9946255 · Cited by 17
Zhu, X., Yang, Z., He, Z., Hu, J., Yin, T., Bai, H., Li, R., Cai, L., Guo, H., Li, M., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.965890 · Cited by 17
Liu, Q., Huang, Y., Wang, M., Jiang, H., & Zhang, X. (2022) · Andrology · doi:10.1111/andr.13355 · Cited by 17
Ehsani, B., Moslehi, N., Mirmiran, P., Tehrani, F. R., Tahmasebinejad, Z., & Azizi, F. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2015.10.007 · Cited by 17
Sîrbu, A. M., Copăescu, C., Martin, S. C., Barbu, C. G., Olaru, R. A., & Fica, S. V. (2012) · PubMed · Cited by 17
Renal Cell Carcinoma and Visceral Adipose Index: a new risk parameter
Ötünçtemur, A., Dursun, M., Özer, K., Horsanalı, O., & Özbek, E. (2016) · International braz j urol · doi:10.1590/s1677-5538.ibju.2015.0396 · Cited by 17
“In a previous study, the authors showed that the identification of a routinely applicable indicator for the evaluation of visceral adipose function, with higher sensitivity and specificity than classical parameters [such as waist circumference (WC), BMI, and lipids], could be useful for cardiometabolic risk assessment…”
BackgroundMethodInfluentialVelasco, M. (2017) · Journal of Pharma & Pharmaceutical Sciences · doi:10.24218/vjpps.2017.20 · Cited by 17
Aziz, T. A., Hussain, S. A., Mahwi, T., & Ahmed, Z. A. (2018) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s169503 · Cited by 17
Zhou, C., Peng, H., Yuan, J., Lin, X., Zha, Y., & Chen, H. (2018) · BMC Nephrology · doi:10.1186/s12882-018-0996-0 · Cited by 17
Association of Visceral Adiposity Surrogates with Impaired Fasting Glucose in Nonobese Individuals
Li, H. H., Wang, J. M., Ji, Y. X., Lin, L., Li, S. W., Cai, D., Huang, S., Hua, F., & Liu, X. (2020) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2019.0078 · Cited by 17
“VAI is a gender-specific mathematical model that was extrapolated from the linear relationship between BMI and WC 9 and was associated with poor metabolic outcomes in obese individuals.”
Central obesity and risks of cardiovascular events and mortality in prevalent hemodialysis patients
Said, H. W. E., Mohamed, O. M., Said, T. W. E., & Elserwi, A. (2017) · International Urology and Nephrology · doi:10.1007/s11255-017-1568-0 · Cited by 17
Stonehouse, W., Sergi, D., Benassi-Evans, B., James-Martin, G., Johnson, N., Thompson, C. H., & Abeywardena, M. (2021) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa347 · Cited by 16
Saphyakhajorn, W., Sirirat, R., & Sapwarobol, S. (2022) · BMC Nutrition · doi:10.1186/s40795-022-00586-9 · Cited by 16
Yoga practice can reduce metabolic syndrome and cardiovascular risk in climacteric women
Souza, L. A. C. E., Gouvea, T. M., Fernandes, F. C., Carrillo, M. R. G. G., Veloso, V. M., Filho, A. F. S., & Lima, A. A. (2023) · Journal of Behavioral Medicine · doi:10.1007/s10865-023-00420-y · Cited by 16
“…(LAP) = [WC (cm)–58] × TG (mmol/L)] (Kahn, 2005); Visceral Adiposity Index (VAI) = WC/[36.58 + (1.89 × BM I)] × [TG/0.81 (mmol/L)] × [1.52/HDLc (mmol/L)] (Amato et al., 2010); and Atherogenic Index of Plasma (AIP) = log [TG (mmol/L) / HDLc (mmol/L)] (Dobiásová & Frohlich, 2001) for…”
InfluentialMohammadi, F., Yadegar, A., Rabizadeh, S., Ayati, A., Seyedi, S. A., Nabipoorashrafi, S. A., Esteghamati, A., & Nakhjavani, M. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02010-6 · Cited by 16
Huang, Q., Tan, X., Wu, Q., Zhao, H., Chen, H., Yu, X., Wang, J., Huang, X., Huang, Y., Wei, J., et al. (2024) · Biomarkers in Medicine · doi:10.2217/bmm-2023-0725 · Cited by 16
Zheng, D., Zhao, C., Ma, K., Ruan, Z., Zhou, H., Wu, H., & Lu, F. (2024) · PLoS ONE · doi:10.1371/journal.pone.0299285 · Cited by 16
Acheampong, E., Adua, E., Obirikorang, C., Anto, E. O., Peprah‐Yamoah, E., Obirikorang, Y., Adu, E. A., Opoku‐Yamoah, V., Nyantakyi, M., Taylor, J., et al. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01491-7 · Cited by 16
Zhang, J., Li, M., Wang, T., Tian, W., Ju, J., & Xu, H. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1523731 · Cited by 16
“VAI re fl ects changes in adipose function (12) and is also linked to cardiometabolic risk (11).”
Bozorgmanesh, M., Hadaegh, F., Sheikholeslami, F. H., Ghanbarian, A., & Azizi, F. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-69 · Cited by 16
Noto, D., Cefalu, A. B., Barbagallo, C. M., Ganci, A., Cavera, G., Fayer, F., Palesano, O., Spina, R., Valenti, V., Altieri, G. I., et al. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.07.003 · Cited by 16
Yang, H. J., Li, H., Han, L., Zhang, L., & Zhou, Y. (2020) · Blood Pressure Monitoring · doi:10.1097/mbp.0000000000000469 · Cited by 16
Cicero, A. F. G., Fogacci, F., Grandi, E., Rizzoli, E., Bove, M., D’Addato, S., & Borghi, C. (2020) · Nutrients · doi:10.3390/nu12103063 · Cited by 16
“[17] Systolic (SBP) and diastolic blood pressure (DBP) were assessed with a standard sphygmomanometer three times at 1-min interval, with the subject in the seated position and after 5 min of quiet rest.”
MethodAlissa, E. M., Algarni, S. A., Khaffji, A. J., & Mansouri, N. M. A. (2020) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2020.200116 · Cited by 16
Iceta, S., Dadar, M., Daoust, J., Scovronec, A., Leblanc, V., Pelletier, M., Biertho, L. D., Tchernof, A., Bégin, C., & Michaud, A. (2021) · Brain Sciences · doi:10.3390/brainsci11091158 · Cited by 16
Li, Q., Wang, L., Wu, J., Wang, J., Wang, Y., & Zeng, X. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-058517 · Cited by 16
Baş, M., Göçer, D. B., BİÇER, N. Ç., & Hajhamidiasl, L. (2022) · Nutrición Hospitalaria · doi:10.20960/nh.03966 · Cited by 16
Li, R., Liu, J., Han, P., Shi, R., Zhao, L., & Li, J. (2023) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16196 · Cited by 16
Rodríguez-Mortera, R., Luévano‐Contreras, C., Solorio, S., Caccavello, R. J., Bains, Y., Garay‐Sevilla, M. E., & Gugliucci, A. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-0733 · Cited by 16
Being Metabolically Healthy, the Most Responsible Factor for Vascular Health
Rhee, E. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.42.1.19 · Cited by 16
Visceral adiposity index (VAI), a powerful predictor of incident hypertension in prehypertensives
Fiorentino, T. V. (2018) · Internal and Emergency Medicine · doi:10.1007/s11739-018-1849-3 · Cited by 16
RELATION OF ANTHROPOMETRIC INDEXES AND CORONARY HEART DISEASE
Shalnova, S. A., Деев, А. Д., Аркадьевна, М. Г., Balanova, J. A., Имаева, А. Э., Владимировна, К. А., Евстифеева, С. Е., Шепель, Р. Н., Rotar, O. P., Nedogoda, S. V., et al. (2018) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2018-3-11-16 · Cited by 16
Baloğlu, İ., Türkmen, K., Selçuk, N. Y., Tonbul, H. Z., Özçiçek, A., Hamur, H., Iyısoy, M. S., & Akbaş, E. M. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0892-4290 · Cited by 16
Mousavizadeh, Z., Hosseini‐Esfahani, F., Javadi, A., DANESHPOUR, M. S., Akbarzadeh, M., Javadi, M., Mirmrian, P., & Azizi, F. (2020) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2020.04.002 · Cited by 16
Abruzzese, G. A., Gámez, J. M. C., Belli, S., Levalle, O. A., Mormandi, E. A., Otero, P., Graffigna, M., Cerrone, G. E., & Motta, A. B. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2020.1769061 · Cited by 16
Guarnotta, V., Vigneri, E., Pillitteri, G., Ciresi, A., Pizzolanti, G., & Giordano, C. S. D. S. (2018) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-018-0341-6 · Cited by 16
Self-citationJung, J. Y., Ryoo, J., Oh, C., Choi, J., Chung, P., Hong, H. P., & Park, S. K. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej19-0008 · Cited by 16
Cardiometabolic risk in patients with polycystic ovary syndrome.
Ozegowska, K., & Pawelczyk, L. (2015) · Polish Gynaecology · doi:10.17772/gp/59131 · Cited by 15
Tsou, M.-T. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab028 · Cited by 15
“Continuing epidemiological evidence shows that simple and cheap anthropometric methods can be used to predict Mets, such as BRI [14], ABSI [19], and VAI [35], which have historically been used for clinical diagnosis [17, 19, 35].”
BackgroundMethodRiccio, A., Fortin, E., Mellbin, L., Norhammar, A., Näsman, P., Rydén, L., Sesti, G., & Ferrannini, G. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-023-02093-y · Cited by 15
Metadata
- Authors
- Amato, M. C., Giordano, C., Galia, M., Criscimanna, A., Vitabile, S., Midiri, M., Galluzzo, A., & for the AlkaMeSy Study Group
- Affiliations
- University of Palermo (IT)
- Corresponding author
- Galluzzo, Aldo
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-01-12
- Volume
- 33
- Issue
- 4
- Pages
- 920-922
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2845052
- OpenAlex
- W2125944762
- Cited by
- 1,751
- References
- 14
- Citations by year
- 2026: 157 · 2025: 293 · 2024: 211 · 2023: 184 · 2022: 198 · 2021: 157 · 2020: 121 · 2019: 106 · 2018: 66 · 2017: 52 · 2016: 56 · 2015: 43 · 2014: 46 · 2013: 28 · 2012: 17
- FWCI
- 14.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- visceral adiposity index, visceral fat, waist circumference, body mass index, triglycerides, HDL cholesterol, metabolic syndrome, cardiovascular risk, cerebrovascular risk, insulin sensitivity, cardiometabolic risk
- MeSH terms
- Adult, Aged, Aged, 80 and over, Cardiovascular Diseases, Female, Humans, Cholesterol, HDL, Male, Middle Aged, Risk Factors, Triglycerides, Body Mass Index, Logistic Models, Intra-Abdominal Fat, Waist Circumference, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.